NABIO

New bioactive agents based on natural products

Coordinatore	THE UNIVERSITY OF NOTTINGHAM    more  Organization address address: University Park city: NOTTINGHAM postcode: NG7 2RD contact info Titolo: Mr. Nome: Paul Cognome: Cartledge Email: send email Telefono: +44 115 951 5679 Fax: +44 115 951 3633
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	173˙240 €
EC contributo	173˙240 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2009-IEF
Funding Scheme	MC-IEF
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-06-01   -   2012-05-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	THE UNIVERSITY OF NOTTINGHAM  Organization address address: University Park city: NOTTINGHAM postcode: NG7 2RD contact info Titolo: Mr. Nome: Paul Cognome: Cartledge Email: send email Telefono: +44 115 951 5679 Fax: +44 115 951 3633	UK (NOTTINGHAM)	coordinator	173˙240.80

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'More than 1 in 3 people in the EU will develop cancer during their lifetime. Despite huge investment, insufficient new bioactive molecules are emerging, and there is urgent need for a different approach to research in this area. Drawing inspiration from Nature, the Fellow will investigate natural products with anticancer potential. The objective of the IEF is to support the career development of a talented researcher, to improve and develop her skills in preparation for an independent scientific career. The research objectives are to exploit the medicinal activity in naturally occurring quinones in an interdisciplinary programme involving chemical synthesis of the natural compounds and analogues, and their biological evaluation, maximizing the synergy between the Fellow and the Host Laboratory. The objectives will be measured against: • development of innovative chemical routes to bioactive quinones, including natural products and analogues; • biological evaluation of novel compounds as potential therapeutic agents; • publication of high quality papers; • establishment of research collaborations between UK and Italian groups. The project brings together complementary scientific communities in research aimed at developing novel therapeutic agents, particularly for cancer. The substantial training element will be of huge benefit to the Fellow in establishing her independent academic career by complementing and reinforcing her medicinal chemistry background with synthetic organic chemistry.'